Carcinoma, Renal Cell
Showing NaN - NaN of 25
Carcinoma, Renal Cell Trial in Worldwide (tivozanib HCl, Sorafenib)
Completed
- Carcinoma, Renal Cell
- tivozanib hydrochloride
- Sorafenib
-
Phoenix, Arizona
- +190 more
Jan 18, 2022
Carcinoma, Renal Cell Trial in Worldwide (Regorafenib (Stivarga, BAY73-4506))
Completed
- Carcinoma, Renal Cell
- Regorafenib (Stivarga, BAY73-4506)
-
Los Angeles, California
- +17 more
Jan 27, 2021
Lymphoma, Non-Hodgkin, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse Trial in Worldwide (PF-05082566, rituximab)
Completed
- Lymphoma, Non-Hodgkin
- +6 more
-
Duarte, California
- +41 more
Mar 4, 2020
NSCLC, Carcinoma, Renal Cell, Breast Tumors Trial in United States (SGN-2FF, pembrolizumab)
Terminated
- Carcinoma, Non-Small-Cell Lung
- +7 more
-
Birmingham, Alabama
- +10 more
Jul 17, 2019
Carcinoma, Renal Cell Trial in Houston (Sunitinib, Temsirolimus, Sorafenib)
Terminated
- Carcinoma, Renal Cell
- Sunitinib
- +5 more
-
Houston, TexasUTHealth Memorial Hermann Cancer Center
Sep 12, 2018
Carcinoma, Renal Cell Trial in Houston (Bevacizumab, Interleukin-2)
Terminated
- Carcinoma, Renal Cell
-
Houston, TexasBaylor College of Medicine - Methodist Hospital
Mar 15, 2016
Carcinoma, Renal Cell Trial in Houston (Pegylated Alfa Interferon, sunitinib, erlotinib)
Terminated
- Carcinoma, Renal Cell
- Pegylated Alfa Interferon
- +2 more
-
Houston, TexasBaylor College of Medicine - Methodist Hospital
Mar 15, 2016
Carcinoma, Renal Cell Trial in Houston (Sorafenib)
Completed
- Carcinoma, Renal Cell
-
Houston, TexasMethodist Hospital - Baylor College of Medicine
Mar 15, 2016
Carcinoma, Renal Cell Trial in Houston (RAD001)
Completed
- Carcinoma, Renal Cell
-
Houston, TexasBaylor College of Medicine - Methodist Hospital
Mar 15, 2016
Carcinoma, Renal Cell Trial in Houston (TroVax® (Immunological Vaccine Therapy), Interferon-alpha)
Completed
- Carcinoma, Renal Cell
- TroVax® (Immunological Vaccine Therapy)
- Interferon-alpha
-
Houston, TexasBaylor College of Medicine - Methodist Hospital
Mar 15, 2016
Carcinoma, Renal Cell Trial in United Kingdom, United States (Sorafenib (Nexavar, BAY43-9006), Placebo)
Completed
- Carcinoma, Renal Cell
- Sorafenib (Nexavar, BAY43-9006)
- Placebo
-
Chicago, Illinois
- +6 more
Dec 18, 2014
Carcinoma, Renal Cell, Lymphoma, Non-Hodgkin Trial in United States (SGN-75)
Completed
- Carcinoma, Renal Cell
- Lymphoma, Non-Hodgkin
-
Birmingham, Alabama
- +8 more
Dec 17, 2014
Carcinoma, Renal Cell Trial in Canada, United States (Sorafenib (Nexavar, BAY43-9006))
Completed
- Carcinoma, Renal Cell
- Sorafenib (Nexavar, BAY43-9006)
-
Bessemer, Alabama
- +319 more
Aug 5, 2014
Carcinoma, Renal Cell, Kidney Tumors Trial in Worldwide (Interferon Alfa, CCI-779, Interferon Alfa and CCI-779)
Completed
- Carcinoma, Renal Cell
- Kidney Neoplasms
- Interferon Alfa
- +2 more
-
Little Rock, Arkansas
- +153 more
Sep 24, 2012
Carcinoma, Renal Cell Trial in Worldwide (Interferon-alfa, SU011248)
Completed
- Carcinoma, Renal Cell
-
Jonesboro, Arkansas
- +123 more
Jan 19, 2010
Carcinoma, Renal Cell Trial in United States (Recombinant Human Lactoferrin)
Completed
- Carcinoma, Renal Cell
- Recombinant Human Lactoferrin
-
Los Angeles, California
- +5 more
Apr 8, 2008
Carcinoma, Renal Cell Trial in Netherlands, United States (ABT-510/Thrombospondin-1 mimetic)
Completed
- Carcinoma, Renal Cell
- ABT-510/Thrombospondin-1 mimetic
-
Scottsdale, Arizona
- +17 more
Aug 13, 2007
Carcinoma, Renal Cell, Urogenital Tumors, Urologic Tumors Trial in Houston (motexafin gadolinium)
Completed
- Carcinoma, Renal Cell
- +3 more
- motexafin gadolinium
-
Houston, TexasMethodist Hospital
Mar 2, 2007